Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Wistuba

Showing results (61-70 of 127) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Suyu Liu, Kangyu Lin, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Coordinated translational control of multiple immune checkpoints by the integrated stress response pathway in lung cancerShayna Thomas-Jardin, Shruthy Suresh, Ariana Arce, et al.
Journal for Immunotherapy of Cancer|July 16, 2021
Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) StudyJanis M Taube, Kristin Roman, Elizabeth L Engle, et al.
JCO Precision Oncology|February 17, 2022
Germline and Somatic Smoothened Mutations in Non-Small-Cell Lung Cancer Are Potentially Responsive to Hedgehog Inhibitor VismodegibAnne S Tsao, Ignacio Wistuba, Dianren Xia, et al.
Oncotarget|March 28, 2018
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancerDaniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, et al.
Oncoimmunology|August 13, 2024
Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin LymphomaJosé L Solórzano, Victoria Menéndez, Edwin Parra, et al.
Archives of Pathology & Laboratory Medicine|September 14, 2012
Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classificationWilliam D Travis, Elisabeth Brambilla, Masayuki Noguchi, et al.
Experimental Cell Research|November 20, 2021
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancerHei-Cheul Jeung, Roisin Puentes, Alexander Aleshin, et al.
Cancer Research|July 29, 2010
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferationDi Cai, David S Shames, Maria Gabriela Raso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Pageof 13

Showing results (61-70 of 127) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal CanalVan K Morris, Suyu Liu, Kangyu Lin, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Coordinated translational control of multiple immune checkpoints by the integrated stress response pathway in lung cancerShayna Thomas-Jardin, Shruthy Suresh, Ariana Arce, et al.
Journal for Immunotherapy of Cancer|July 16, 2021
Multi-institutional TSA-amplified Multiplexed Immunofluorescence Reproducibility Evaluation (MITRE) StudyJanis M Taube, Kristin Roman, Elizabeth L Engle, et al.
JCO Precision Oncology|February 17, 2022
Germline and Somatic Smoothened Mutations in Non-Small-Cell Lung Cancer Are Potentially Responsive to Hedgehog Inhibitor VismodegibAnne S Tsao, Ignacio Wistuba, Dianren Xia, et al.
Oncotarget|March 28, 2018
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancerDaniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, et al.
Oncoimmunology|August 13, 2024
Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin LymphomaJosé L Solórzano, Victoria Menéndez, Edwin Parra, et al.
Archives of Pathology & Laboratory Medicine|September 14, 2012
Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classificationWilliam D Travis, Elisabeth Brambilla, Masayuki Noguchi, et al.
Experimental Cell Research|November 20, 2021
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancerHei-Cheul Jeung, Roisin Puentes, Alexander Aleshin, et al.
Cancer Research|July 29, 2010
Steroid receptor coactivator-3 expression in lung cancer and its role in the regulation of cancer cell survival and proliferationDi Cai, David S Shames, Maria Gabriela Raso, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Pageof 13